Ali Faraz 4
4 · Tenaya Therapeutics, Inc. · Filed May 16, 2025
Insider Transaction Report
Form 4
Ali Faraz
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-05-16$0.44/sh−3,189$1,412→ 317,325 total
Footnotes (2)
- [F1]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.
- [F2]Includes 259,568 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.